Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05703425 · ClinicalTrials.gov registry record · Phase 2
The Effect of Sulfasalazine on CRH Levels in Pregnant Women
A Phase 2 study of Preterm Birth, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05703425 is a Phase 2 study of Preterm Birth that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 50 participants, below the 4,629-participant average among 37 other Preterm Birth trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05703425, a Phase 2 study of Preterm Birth, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this randomized clinical trial is to assess sulfasalazine as a potential treatment to prevent recurrent preterm birth. The main questions it aims to answer are: * Does sulfasalazine down regulate corticotropin releasing hormone (CRH) levels in pregnant persons with a prior history of preterm birth? * Does sulfasalazine reduce the incidence of recurrent preterm birth in pregnant persons given drug vs. controls? Consenting participants will be randomized to receive sulfasalazine or to a control group and will undergo serial blood draws to assess plasma CRH levels.
Conditions Studied
Interventions
- DRUG Sulfasalazine
Study Locations (1)
New Jersey
- Rutgers Robert Wood Johnson Medical School - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2026-06-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05703425
The ClinicalTrials.gov registry entry for NCT05703425 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,629-participant average among 37 other Preterm Birth trials with a reported enrollment target (99% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Preterm Birth appearing as the primary indexed condition, and to 1 intervention - of which Sulfasalazine is the first listed.
NCT05703425 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT05703425 about?
NCT05703425 is a clinical study titled "The Effect of Sulfasalazine on CRH Levels in Pregnant Women". The goal of this randomized clinical trial is to assess sulfasalazine as a potential treatment to prevent recurrent preterm birth. The main questions it aims to answer are: * Does sulfasalazine down regulate corticotropin releasing hormone (CRH) levels in pregnant persons with a prior history of pr...
What is the current status of trial NCT05703425?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2023-03-01. Estimated completion is 2026-06-30.
What conditions does trial NCT05703425 study?
This clinical trial studies the following conditions: Preterm Birth.
What interventions are being tested in trial NCT05703425?
The interventions under investigation include: Sulfasalazine (DRUG).
Who is sponsoring clinical trial NCT05703425?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05703425 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preterm Birth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes
ACTIVE NOT RECRUITING · Phase 2
-
Reducing Preterm Births in Underserved Pregnant Women
COMPLETED · Phase 2
-
Transition From Donor Milk: a Feasibility Study
RECRUITING · NA
-
Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)
RECRUITING · Phase 4
-
Reducing Pregnancy Risks: The Mastery Lifestyle Intervention
RECRUITING · NA
-
Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.